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Creating, Protecting, and Using Crop
Biotechnologies Worldwide in an Era of Intellectual
Property
Philip G. Pardey, Bonwoo Koo and Carol Nottenburg*
I. INTRODUCTION
Most crops are grown in places where they did not occur
naturally, but were introduced there incidentally or
intentionally.
The
international
development
and
dissemination of new and improved seed varieties have been
the basis for productivity improvement in agriculture since
crops were first domesticated about ten millennia ago.1
Initially, the movement of plant material involved farmers
carrying seed as they migrated to new areas.2 Columbus
returned from his voyage to the New World in the latter part of
the fifteenth century laden with new plants that ushered in an
extended era of state-sponsored expeditions to gather and
evaluate plant materials the world over.3 For most of that

* Philip Pardey is Professor of Science and Technology Policy in the
Department of Applied Economics, University of Minnesota. Bonwoo Koo is a
Research Fellow at the International Food Policy Research Institute,
Washington D.C. Carol Nottenburg is a Principal of Cougar Patent Law,
formerly Chief Legal Officer and Director, Cambia IP Resource, CAMBIA,
Canberra, Australia. The authors thank Doug Ashton, Eduardo CasteloMagalhães, Barry Ryan, and Patricia Zambrano for their help in preparing
this paper. Brian Wright provided insightful comments for which we are
especially grateful. This paper is a revised and updated version of a paper
first presented at the WIPO-UPOV Symposium on Intellectual Property
Rights in Plant Biotechnology held on October 24, 2003 at the World
Intellectual Property Organization (WIPO) and International Union for the
Protection of New Varieties of Plants (UPOV) headquarters, Geneva.
1. See Philip Pardey & Brian Wright, Agricultural Research &
Development, Productivity & Global Food Products, in PLANTS, GENES AND
CROP BIOTECHNOLOGY (M.J. Chrispeels & D.E. Sadava, eds., 2d ed. 2003).
2. Id.
3. Id.
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time, new crop varieties were largely treated as common
property, shared freely among farmers and countries and
generating billions of dollars of benefits worldwide.4
The era of free and unencumbered access to new crop
varieties appears to be passing. This has implications beyond
the movement and marketing of new crop varieties; it affects
their creation as well. Scientific crop breeding, drawing on
Mendelian Laws of Heredity, began in earnest about a century
ago.5 For many countries, varietal innovations continued to
rely heavily on introduced germplasm, and the international
spillovers of germplasm, breeding techniques, and know-how
continued to be integral to these crop improvement efforts.6
While substantial germplasm flowed from poorer countries into
the rich ones, enhanced germplasm also moved back to the
poorer parts of the world.7 This reverse flow accelerated as the
Green Revolution took hold, beginning in the 1960s, as
developing-country farmers took up improved varieties in a big
way and local breeding efforts screened and adapted these
varietal spill-ins to better deal with local agroecological
realities and production constraints.8
Throughout all these changes, crop improvement has been,
and largely remains, a cumulative or sequential innovation
process—new varieties build directly on the selection and
breeding efforts of farmers and scientists of yesteryear. A new
twist has come with the advent of modern biotechnology tools.
Now the genetic makeup of new varieties are altered by the
“conventional or classical” genetic manipulation techniques
practiced formally by scientists for the past 100 years (and less
formally by farmers for eons prior to that), or by bioengineered
techniques involving the purposeful insertion of gene fragments
into plants from other plants or other organisms using genomic
and transformation technologies developed within the past two

4. Sarah Boettiger, et al., Intellectual Property Rights for Plant
OF
PLANT
Biotechnology:
International
Aspects,
in
HANDBOOK
BIOTECHNOLOGY (P. Christou & H. Klee eds. 2004)
5. See PHILIP G. PARDEY & NIENKE M. BEINTEMA, SLOW MAGIC:
AGRICULTURAL R&D A CENTURY AFTER MENDEL 3 (Int’l. Food Policy Research
Inst. Food Policy Report, Oct. 2001).
6. See id.
7. See id.
8. See Robert Evenson & Douglas Gollin, Assessing the Impact of the
Green Revolution, 1960 to 2000, 300 SCIENCE 758 (2003).
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decades.9 Like the crop varieties themselves, the tools of crop
manipulation are increasingly encumbered by intellectual
property, making the future of crop-improvement inextricably
tied to the future of the biotechnologies increasingly used to
manipulate them.
Whether these changing market, scientific, and intellectual
property regimes will help or hinder efforts to develop and
disseminate varietal technologies in the future, and especially
the crop innovations required by the developing world, is an
open question. This paper surveys and reports newly compiled
evidence on the research and, especially, the intellectual
property landscapes regarding plant biotechnologies as a step
toward resolving these questions.
II. CROP BIOTECHNOLOGY CREATION
Crop biotechnologies are not necessarily used or protected
where created. The location and structure of the relevant
research and development sectors are important as a basis for
analyzing the patterns of intellectual property rights in the
resulting crop innovations and their uptake worldwide.
A. RESEARCH SPENDING
In 1995 about half a trillion U.S. dollars were invested in
all public and privately financed science worldwide, of which
eighty-five percent could be attributed to rich countries.10
Agricultural research accounted for thirty-three billion dollars,
or nearly seven percent, of all private and public spending on

9. All crops are genetically modified, making the mnemonic “GMOs”
(genetically modified organisms) misleading in ways that seem to have
profoundly affected peoples’ perceptions about the latest set of cropimprovement techniques. Among the continuum of genetic modification
methods, it is useful to distinguish between classically bred crops using
techniques like hybridization that became commonplace among scientific
breeders beginning a century ago, and varieties whose DNA have been
manipulated with bioengineering techniques like the ballistic gun or
Agrobacterium-mediated transformations of DNA that form the forefront of
present crop improvement methods.
Some modern varieties are
conventionally bred but incorporate herbicide tolerant genes identified using
modern genomic methods, confounding efforts to neatly classify crop varieties.
For a more complete description of these technologies, see MAARTEN J.
CHRISPEELS & DAVID E. SADAVA, PLANTS, GENES, AND CROP BIOTECHNOLOGY
(2d ed. 2002).
10. See PARDEY & BEINTEMA, supra note 5, at 11 tbl.B4.
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science.11
The public share of agricultural investment was
substantial, but is now flagging.
Worldwide, public
investments in agricultural research nearly doubled in
inflation-adjusted terms over the past two decades, from an
estimated $11.8 billion in 1976 to nearly twenty-two billion
dollars in 1995.12 Yet for many parts of the world, growth in
spending during the 1990s slowed dramatically. In the rich
countries, public investment grew just 0.2 percent annually
between 1991 and 1996 compared with 2.2 percent per year
during the 1980s.13 In Africa, there was no growth at all.14 In
Asia, the 4.4 percent annual growth figure compared with 7.5
percent the previous decade.15
The distribution of spending on agricultural research has
shifted as well. In the 1990s, for the first time, developing
countries as a group spent more on public agricultural research
than the developed countries.16 For example, a handful of rich
countries accounted for $10.2 billion dollars in public
spending.17 In 1995 the United States, Japan, France and
Germany accounted for two-thirds of this public research, about
Three developing
the same as two decades before.18
countriesChina, India, and Brazilspent forty-four percent
of the developing world’s public agricultural research money in
1995, up from thirty-five percent in the mid-1970s.19
As indicated in Table 1, by the mid-1990s about one-third
of the thirty-three billion dollar total public and private
agricultural research investment worldwide was private.20 But
little of this research takes place in the developing world. The
overwhelming majority ($10.8 billion, or ninety-four percent, of
the global total in 1995) is conducted in developed counties,

11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

Id. at 10.
Id. at 3.
Id.
Id. at 4 tbl.1.
See PARDEY & BEINTEMA, supra note 5, at 4 tbl.1.
Id.
Id.
Id.
Id. at 4.
Id. at 10.
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where private research is over half of all expenditures.21 In
developing countries, the private share of research is just five
percent, and public funds are still the major source of support.22
TABLE 1: PRIVATE AND PUBLIC AGRICULTURAL RESEARCH AND
DEVELOPMENT INVESTMENTS, CIRCA 199524
Expenditures
Public

Private

Shares
Total

(million 1993 international dollars)

Public

Private

Total

(percent)

Developing 11,469
countries

672

12,141

94.5

5.5

100

Developed 10,215
countries

10,829

21,044

48.5

51.5

100

Total

11,511

33,204

65.3

34.7

100

21,692

Private agricultural research is displacing public research
generally and specifically regarding the development of new
varieties of crops that have high commercial value.25 This
tendency is especially pronounced in countries like the United
States where private agricultural research and development
was ninety percent of public spending in 1960, growing to 133

21. See PARDEY & BEINTEMA, supra note 5, at 10 tbl.2.
22. Id.
24. Id. Drawing together estimates from various sources meant there
were unavoidable discrepancies in what constitutes “private” and “public”
research. For example, the available data for Asia includes nonprofit producer
organizations as part of private research, whereas Pardey and Beintema opted
to include research done by nonprofit agencies as part of public research in
Latin America and elsewhere when possible.
25. See id. at 12.
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percent by 1996, the latest year for which comparable publicprivate data are available.26 Private investments, fueled by
agricultural biotechnology research, gravitate to techniques
which promise large markets, are protected by intellectual
property rights, and are easily transferable across
agroecologies. These included food processing and other postharvest technologies and chemical inputs including pesticides,
herbicides and fertilizers.27 Hence, while private research is
much more geographically concentrated than public research,
many of its fruits may be more easily transferred across
borders and agroecological zones. Even so, private research is
far less likely in products or methods with small markets, weak
intellectual property protection, and limited transferabilityprecisely the situations in which most poor farmers are found.
B. RESEARCH INTENSITIES AND STOCKS OF KNOWLEDGE
One way to gauge the commitment of agricultural research
funds, public or private, is to compare them to national
agricultural output, rather than measuring them in absolute
terms.
This relative measure captures the intensity of
investment in agricultural research as a percentage of
agricultural gross domestic product (GDP), not just the amount
of total research spending.28 In 1995 developed countries spent
$5.43 on public and private agricultural research and
development for every one hundred dollars of agricultural
output, compared with just sixty-six cents per one hundred
dollars of output for developing countries.29 The eightfold
difference in total research intensities illustrates the size of the
technological gap in agriculture between rich and poor
countries. Moreover, the situation is growing worse. The
difference in public research intensity ratios was 3.5−fold in the
1970s, compared with 4.3−fold now.30 An even wider gap would
have opened up if private spending was also factored in.31
These trends may actually understate the scientific
knowledge gap. Science is a cumulative endeavor, with a

26.
27.
28.
29.
30.
31.

See generally id.
See id. at 12.
See PARDEY & BEINTEMA, supra note 5, at 13.
See id. at 13-14.
See id.
See id.
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snowball effect. Innovations beget new ideas and further
rounds of innovation or additions to the cumulative stock of
knowledge. The sequential and cumulative nature of scientific
progress and knowledge is starkly illustrated by cropimprovement. It generally takes seven to ten years of breeding
to develop a uniform, stable, and superior variety.32 But
breeders of today build on a base of knowledge built up by
breeders of yesteryear.33 The cumulative nature of this process
means that past discoveries and related research are an
integral part of contemporary agricultural innovations.
Conversely, the loss of a variety, or the details of the breeding
histories that brought it about, means the loss of accumulated
past research to the present stock of knowledge. “Providing
adequate funding for research is thus only part of the science
story. Putting in place the policies and practices to accumulate
innovations and increase and preserve the stock of knowledge
is an equally important and almost universally unappreciated
foundation.”34
Estimates of the stocks of scientific knowledge arising from
public and private research conducted in the United States and
Sub-Saharan Africa have been developed by Philip G. Pardey
and Nienke Beintema.35 In their report, Slow Magic, Pardey
and Beintema compared historical research spending with the
They examined historical
agricultural GDP for 1995.36
research spending starting from 1850 for the United States and
1900 for Africa and allowed for a gradual diminution of the

32. See id. at 15.
33. See BONWOO KOO & BRIAN D. WRIGHT, ECONOMICS OF PATENTING A
RESEARCH TOOL 3-5 (Int’l Food Policy Research Inst., Environment and
Production Technology Division Discussion Paper No. 88, Jan. 2002), available
at http://www.ifpri.org/.
34. PARDEY & BEINTEMA, supra note 5, at 15. Discoveries and data that
are improperly documented or inaccessible (and so effectively exist only in the
minds of the relevant researchers) are lost from the historical record when
researchers retire from science. These “hidden” losses seem particularly
prevalent in cash-strapped research agencies in the developing world, where
inadequate and often irregular amounts of funding limit the functioning of
libraries, data banks and gene banks, and hasten staff turnover. There can
also be catastrophic losses, tied to the political instability that is a root cause
of hunger. Civil strife and wars cause an exodus of scientific staff, or at least a
flight from practicing science. Id.
35. Id. at 15-17.
36. See id. at 17.
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effect of distant past research and development spending on
money measures of the current stock of knowledge.37 They
found that the accumulated stock of knowledge in the United
States was about eleven times more than the amount of
agricultural output produced in that year.38 In other words, for
every $100 of agricultural output there existed a $1,100 stock of
knowledge to draw upon.39 In Africa, the stock of knowledge in
1995 was actually less than the value of African agricultural
output.40 The ratio of the U.S. knowledge stock relative to U.S.
agricultural output in 1995 was nearly twelve times higher
Stocks of
than the corresponding amount for Africa.41
knowledge measures provide a better basis for evaluating the
developed versus developing country’s capacity for actually
carrying out crop biotechnologies.
In fact, the overall
differences may understate the effective gaps for this advanced
area of agricultural research and development. These gaps also
underscore the immensity, if not the outright impossibility, of
playing “catch-up,” in addition to the need to transfer
knowledge across borders and continents.
C. BIOTECHNOLOGY TRIALS
Absent meaningful data on “crop-related biotechnology
research” spending, the only indication of the location of crop
biotechnology research are data on the number of field trials
“Crop-related biotechnology
conducted internationally.42
research” can be difficult to define. “Biotechnology” can run the
whole gambit from conventional breeding through cultivating
methods to genomic and bioengineering techniques.
In
addition, many biotechnology techniques developed with
spending directed to the health sciences have agricultural
applications as well. Focusing their search solely on croprelated biotechnology research, Pardey and Beintema compiled
data on the number of field trials conducted on bioengineered
crops from 1987 through December 2000 grouped by the

37.
38.
39.
40.
41.
42.

See id. at 15-17.
Id. at 17.
Id.
PARDEY & BEINTEMA, supra note 5, at 17
Id.
See id. at 18.
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regions in the world where the trials were conducted.43 These
data, which are summarized in Table 2, indicates that a total of
twenty-seven countries conducted trials on fourteen different
crops and 183 different “events,” each event involving the
insertion of a specific gene in a particular crop, resulting in the
expression of a trait in that crop. For example, insertion of the
Bt cry1(c) gene into a particular cotton variety is considered an
event.

43. See id. at 18. As indicators of the level of bioengineering research
effort, these data must be taken with a grain of salt. To meaningfully assess
the distribution of transgenic crops being tested in the ground, one would like
the notion of “field trial” to be standardized across countries. One option is to
count each location as a separate instance, but in the United States a
“location” can have many sites. For example, test 01-024-26n in the APHIS
database contains Pennsylvania as one location, but there are 313 sites
comprising a total of 1,838 acres. See id. Likewise, Canada lists field trials
conducted at multiple sites within a province as one field trial, but it is not
clear if all the data for all the other countries are reported similarly. See id.
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TABLE 2: FIELD TRIALS OF BIOENGINEERED CROPS BY REGIONS
OF THE WORLD44
Number of Approved

Field Trials

Events/crops

Number of

Countries

Events45

Crops

Countries

Share of

Trials

Global

Private
in-country

total

total

(percentage)
Developed
Countries

19

160

14

20

9,701

84.2

na

United States

1

49

14

1

6,337

55

83.4

Canada

1

49

4

1

1,233

10.7

63.9

All others

17

62

5

18

2,131

18.5

na

8

23

4

19

1,822

15.8

na

Developing
Countries
Argentina

1

7

3

1

393

3.4

90.1

China

1

5

4

1

45

0.4

na

All others

6

11

3

17

1,384

12

na

27

183

14

39

11,523

100

na

Total

Eighty-four percent of the world’s trials were conducted in
rich countries.46 Two-thirds of that total was in the United
States and Canada alone.47 This points to a biotechnology
research gap between rich and poor countries that is even more
pronounced than the gap in overall agricultural research and
development spending in which sixty-four percent of global
agricultural research and development was conducted in rich

44. Id. at 18. The notation “na” designates that the information is not
available. The data is through December of 2000 where available. For the
United States and Canada, and perhaps other countries, a single “trial” may
consist of tests at different sites.
45. Data through to December 2000 where available.
46. See id.
47. See PARDEY & BEINTEMA, supra note 5, at 10 tbl.2.
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counties.48 Two fundamental factors may account for much of
the marked spatial asymmetry in agricultural biotechnology
research: who conducts the research and the nature of the
science itself. First, as indicated in Table 2, the preponderance
of these biotechnology trials are conducted by private firms and
most of the world’s private agricultural research and
development takes place in rich counties. Second, this type of
cutting-edge research requires access to highly skilled
scientists; well-functioning scientific infrastructure that
provides ready access to reagents and a myriad of laboratory
equipment and supplies, and technical information; and the
appropriately trained support staff to help carry out the
research. Even though most of the trials are conducted by
private firms, the sophistication of the research involved and
its pace of change mean that “applied” aspects of the
biosciences are likely to receive significant spillovers from ongoing basic research and from accumulated stocks of scientific
knowledge arising from past research. Both of these elements
are much more readily supplied in rich rather than poor
countries. Indeed, it is the localized spillovers from university
research often involving tacit knowledge embodied in the
scientific and technically trained people of university
communities that influence the location of industrialized
research and development.49
III. AN ECONOMIC PRIMER ON INTELLECTUAL
PROPERTY RIGHTS
Research and development, like almost all other aspects of
life, is an economic activity. As a consequence, who pays for or
performs the research, where it is performed, and who gains
and loses are all influenced by economic incentives. The degree
to which innovators can appropriate the fruits of their
endeavors lies at the heart of the incentives to invest, giving
rise to pervasive policies worldwide to assign property rights to
innovations in an effort to better align private incentives with

48. See id.
49. See JAMES D. ADAMS, COMPARATIVE LOCALIZATION OF ACADEMIC AND
INDUSTRIAL SPILLOVERS 2 (Nat’l Bureau of Econ. Research Working Paper No.
8292, May 2001), available at http://www.nber.org/papers/w8292; see also
Gregory D. Graff, et al., Agricultural Biotechnology's Complementary
Intellectual Assets. 85 REV. OF ECON. AND STAT. 349 (2003).
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social interests.
The conventional rationale for protecting intellectual
property by patents or other means is to provide some
proprietary or “monopoly” rights to an invention—albeit
circumscribed and exclusionary in nature—in exchange for
The
public disclosure of the details of the invention.50
information that is disclosed may be useful for further
innovation by others. However, the monopoly right also
encourages invention directly, and the social value of the right
tends to include surplus above the private value. Thus, the
private and social benefits of patents include wide diffusion of
the creation of aspects of new or advanced technologies. The
costs are transitory, that is for the life of a patent, and entail
higher-than-otherwise prices or constrained choices of
innovations subject to some monopolistic behavior. However,
this conventional, static, one-off view of invention does not fully
reflect the dynamic nature of a large part of research and
development.
Much technological change comes in the form of cumulative
innovation processes, whereby the fruits of innovation
frequently materialize as the embodiment of a sequence of prior
innovations. While strong patent protection may stimulate the
earlier-than-otherwise development of a research tool, it can
also delay or deter follow-on innovation due to the transaction
costs of negotiating a license or merger and the ability to
prevent competitors from introducing similar technology.51
Thus the dynamic cost of a patent within a cumulative
innovation scheme—which includes the accumulated costs of
delayed follow-on inventions—is an important policy
consideration that is often neglected when counting the
conventional or static social cost of a patent.52
A special case of cumulative innovation involves the
development of a research tool, that is a product or process

50. WILLIAM D. NORDHAUS, INVENTION, GROWTH AND WELFARE: A
THEORETICAL TREATMENT OF TECHNOLOGICAL CHANGE 3-4 (M.I.T. Press,
1969).
51. See Robert P. Merges & Richard R. Nelson, On the Complex Economics
of Patent Scope, 90 COLUM. L. REV. 839, 874-75 (1990); Michael A. Heller &
Rebecca S. Eisenberg, Can Patents Deter Innovation? The Anticommons in
Biomedical Research, 280 SCIENCE 698 (1998).
52. See KOO & WRIGHT, supra note 33, at 3-5.
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whose only value is as an input to follow-on innovations. In
agricultural biotechnology, a research tool can be a patent on a
DNA sequence modified to enhance the expression of a trait
such as insect-resistance, while the follow-on innovation may
be a new transgenic variety of cotton. Since the patentee of a
research tool can capture revenue only through direct
production of the follow-on innovations, efficient compensation
of the patentee, through licensing, joint ventures, or other
means, is critical in providing the incentive to innovate
research tools. In addition, these efficient mechanisms also
reduce the transaction costs incurred by those contracting for
use of the rights, thereby encouraging the utilization of
research tools by follow-on innovators.
One way of reducing dynamic costs and encouraging
technology transactions is to clarify property rights. The BayhDole Act of 1980 and subsequent legislation, which allowed
U.S. universities, other non-profit institutions, and government
labs to patent and exclusively license federally funded
inventions, was intended to achieve this purpose.53 Firms are
often unwilling to invest significantly in developing and
disseminating innovations lacking clearly defined property
rights. This point was clearly captured by the 1945 Report of
the U.S. House of Representatives, which stated that “what is
available for exploitation by everyone is undertaken by no
one.”54 The main objective of the Bayh-Dole Act is to foster
markets for the transfer of technology, and there is some
evidence the Act has achieved these aims.55 However, the
Bayh-Dole Act is most effective when inventions require heavy
expenditure in downstream technology and product
development, which is not the case for all technologies. In
addition, some have argued that the Act may actually constrain
and delay the flow of fundamental scientific knowledge as
“prior art” concerns impede open scientific discourse through
seminars and the professional literature.56 This could shift the

53. See 35 U.S.C. §§ 200-212 (2000).
54. Adam B. Jaffe, The U.S. Patent System in Transition: Policy
Innovation and the Innovation Process, 29 RES. POL’Y. 531, 534 (2000), quoting
H.R. DOC. NO. 22, at 5 (1945).
55. See Richard Jensen & Marie Thursby, Proofs and Prototypes for Sale:
The Licensing of University Inventions, 91 AM. ECON. REV. 240, 241 (2001).
56. See, e.g., Roberto Mazzoleni & Richard R. Nelson, The Benefits and
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emphasis of university research from fundamental basic
research toward more applied research that is potentially more
rewarding financially for the university or its research faculty,
but not necessarily for society as a whole over the long run.57
The impact of a patent system also depends on the type of
technology itself. Agriculture seeds have special attributes,
most significantly their almost costless reproducible nature,
that merit special attention. Under plant variety protection
schemes, farmers may legally save, reuse, and sometimes sell
seeds in following seasons so that seed firms are faced with
only the residual demand for their seeds in subsequent seasons.
This problem, together with the difficulty of monitoring and
enforcing property rights to seed, makes its legal protection less
valuable than other forms of protection on other products.
Private seed markets have responded to the appropriability
problem by developing hybrid varieties or pursuing genetic use
restriction technologies (GURTs). These methods prevent
seeds from effectively reproducing and serve as a form of
“biological” rather than legal property protection.58
What evidence is there that intellectual property rights
stimulate inventive activity? Although there are no readily
measurable markets for intellectual property rights in which
the benefits and costs of patents, for example, can be easily
evaluated, a few studies have sought to measure the overall
inventive effects of patents. Findings from survey studies
suggest that, with the exception or pharmaceuticals, innovators
rely primarily on other means such as trade secrets or firstmover advantages rather than patent protection to appropriate
the returns from their innovative investment.59 Some have
estimated the private value of patent protection using patent
data and concluded that the distribution of patent-rights values

Costs of Strong Patent Protection: A Contribution to the Current Debate, 27
RES. POL’Y 273 (1998).
57. Mazzoleni & Nelson, supra note 56, at 275-86.
58. Convention on Biological Diversity, Consequences of the Use of the
New Technology for the Control of Plant Gene Expression for the Conservation
and Sustainable Use of Biological Diversity (June 1999), available at
http://www.biodiv.org/doc/meetings/sbstta/sbstta-04/official/sbstta-04-09-rev1en.doc.
59. See Richard C. Levin et al., Appropriating the Returns from Industrial
Research and Development, 1987 BROOKINGS PAPERS ON ECON. ACTIVITY 783,
796 (1987).
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is sharply skewed with most of the value concentrated in a
small number of patents.60 Using European patent renewal
data, Mark Schankerman estimated that the private value of
patent protection was about fifteen to twenty-five percent of the
related research and development expenditure, suggesting a
small impact of patent rights on innovative behavior.61
Most empirical studies, all using U.S. data, have generally
found weak or indeterminate empirical evidence to suggest that
plant breeders’ rights are effective in stimulating investments
in varietal-improvement research.62 Some point out that plant
variety protection does not provide patent-like ex ante
investment incentives, nor generate substantial ex post
Julian Alston and
licensing and enforcement activity.63
Raymond Venner found that varietal rights for wheat in the
United States had little measurable impact on the rate of
technical change in that crop and may simply have served as a
marketing tool.64
Given evidence of the general lack of appropriability from
patent or plant variety protection, why do innovators continue
to apply for intellectual property protection? Even accepting
the claim that practicing patents may not be the primary
means by which large firms recoup their research and
development investments, it can still be an important incentive

60. See Jean O. Lanjouw et al., How to Count Patents and Value
Intellectual Property: The Uses of Patent Renewal and Application Data, 46 J.
INDUS. ECON. 405, 410 (1998).
61. See Mark Schankerman, How Valuable is Patent Protection?
Estimates by Technology Field, 29 RAND J. ECON. 77, 79 (1998) (noting that
although patent protection provides a substantial incentive to research and
development, it does not appear to be the major source of private returns on
inventive activity).
62. See, e.g., Richard K. Perrin et. al., Some Effects of the US Plant
Variety Act of 1970. (N.C. State Univ., Econ. Research Rep’t 46, 1983); Mary K.
Knudson and Carl E. Pray, Plant Variety Protection, Private Funding, and
Public Sector Research Priorities, 73 AM. J. AGRIC. ECON. 882 (1991); Julian
M. Alston & Raymond J. Venner, The Effects of the US Plant Variety
Protection Act on Wheat Genetic Improvement, 31 RES. POL’Y 527 (2002).
63. Mark D. Janis & Jay P. Kesan, U.S. Plant Variety Protection: Sound
and Fury…?, 39 HOUS. L. REV. 727, 776-77 (2002).
64. JULIAN M. ALSTON & RAYMOND J. VENNER, THE EFFECTS OF THE US
PLANT VARIETY PROTECTION ACT ON WHEAT GENETIC IMPROVEMENT 31 (Int’l
Food Policy Research Inst., Environment and Production Technology Division
Discussion
Paper
No.
62,
May
2000),
available
at
http://www.grain.org/docs/eptdp62.pdf.
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mechanism for smaller new entrants and the venture capital
firms that often fund them. Patent portfolios may be critical to
obtaining venture capital or maintaining control of the
technology while downstream innovation is pursued or
production and sales capabilities are established.65 In addition,
both large and small firms use patents to block products of
their competitors and as bargaining chips when negotiating
cross-licensing agreements, as is the case of the semiconductor
industry.66 Strategic patenting behavior that relies on larger
patent portfolios is consistent with rising rates of patenting and
high patent-to-research and development spending ratios, even
absent any perceived increase in the appropriable value of
For some developing countries with newly
patents.67
introduced plant variety rights such as China, a surge in plant
variety protection applications may be explained by an overoptimistic view of the prospective value of varietal rights even
though the current size of the seed market and the cost and
effectiveness of protection do not seem to economically justify
the extent of protection presently being sought.68
IV. CROP BIOTECHNOLOGIES AS PROPERTY
Creating new crop biotechnologies is one thing; protecting
the intellectual property embodied in them is a related but
separate undertaking, with its own set of economic costs and
benefits. Notwithstanding the incentive-to-innovate argument
broached in the previous section, one view is that intellectual
property rights over plant biotechnologies in rich and poor
countries lead to a lock-out phenomenon, that is, the growth in
intellectual property is restricting access to proprietary
research results in ways that curtail the freedom to operate for
research conducted in or on behalf of poor countries to the

65. See Edmund W. Kitch, The Nature and Function of the Patent System,
20 J.L. & ECON. 265, 275-80 (1977); Mazzoleni & Nelson, supra note 56, at
276-80.
66. See Bronwyn H. Hall & Rosemarie Ham Ziedonis, The Patent Paradox
Revisited: An Empirical Study of Patenting in the U.S. Semiconductor
Industry, 1979-1995, 32 RAND J. ECON. 101, 108-11 (2001).
67. See id.
68. BONWOO KOO ET AL., THE ECONOMICS OF GENERATING AND
MAINTAINING PLANT VARIETY RIGHTS IN CHINA 26 (Int’l Food Policy Research.
Inst., Environment and Production Technology Division Discussion Paper No.
100, February 2003), available at http://www.ifpri.org/.
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detriment of developing-country food-security prospects. This
view is commonly held, even in the absence of evidence on the
international pattern of intellectual property protection, a clear
understanding of the effect this has on the rate and direction of
inventive activity, the use to which these inventions are put,
and the trade in agricultural products arising from this
research. What follows is a first pass at describing the
intellectual property rights evidence for plant biotechnologies
internationally.
A. PLANT VARIETY PROTECTION
1. Global trends
Plant breeders’ rights have been available in many rich
countries for at least the past three decades. Germany, for
example, has issued plant breeders’ rights since at least the
1950s and likewise for a few other European countries. The
United States began issuing plant variety protection
certificates (PVPCs) in 1971 for sexually reproduced plants.69
Asexually reproduced plants such as grape vines, fruit trees,
strawberries, and ornamentals that are propagated through
cuttings and graftings have had recourse to intellectual
property protection in the United States since 1930 when the
Plant Patent Act was passed.70 Many middle-income countries
passed plant variety protection legislation during the 1990s in
compliance with their sui generis obligations to offer the
intellectual property rights over plant varieties enshrined in
Article 27.3(b) of the 1995 Trade-Related Aspects of Intellectual
Property (TRIPS) agreement in the World Trade Organization
(WTO).71
Table 3 shows the pattern of applications for plant
breeders’ rights since 1971 for thirty-seven countries grouped
into four classes based on per capita income.72 As indicated,

69. See Janis & Kesan, supra note 63 at 739-40.
70. 35 U.S.C. §§ 161-164 (2000).
71. See Biswajit Dhar, SUI GENERIS SYSTEMS FOR PLANT VARIETY
PROTECTION
OPTIONS
UNDER
TRIPS,
available
at
http://www.geneva.quno.info/pdf/sgco11.pdf.
72. See International Convention for the Protection of New Varieties of
Plants, Dec. 2 1961, as amended on Mar. 19, 1991 (listing the states party to
the
convention
as
of
Oct.
24,
2002),
available
at
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nearly 138,000 plant breeders’ rights applications have been
lodged worldwide since 1971. Some applications were lodged
before 1970, but the number is small (less than three percent)
when compared with the totals reported in Table 3. During the
1970s and 1980s, rich countries accounted for ninety-two to
ninety-six percent of the total applications. Their share
throughout the 1990s declined to average approximately
seventy-five percent in 2001-02.
Plant breeders’ rights
applications filed in upper middle-income countries such as
Argentina, Chile, Czech Republic, Hungary, Poland, Slovakia,
South Africa, and Uruguay grew steadily since the early 1970s,
while reported plant breeders’ rights applications in lower
middle-income countries that now includes Brazil, Bulgaria,
China, Colombia, Romania, the Russian Republic, and Ukraine
began increasing a decade later.

http://www.upov.int/en/publications/gazette/pdf/pub422_24-10-02.pdf
(last
visited Nov. 15, 2004). At its inception in 1961, UPOV included five member
countries: Belgium, France, Germany, Italy, and Netherlands – all highincome countries. By the end of 1992, there were twenty member countries;
by September 2003, there were fifty-three member countries, of which twentyone were high-income, twenty-seven were middle-income, and five were lowincome countries. Id. Notably, under the TRIPs agreement, the “least
developed” countries as defined by WTO are exempt from complying with
Article 27.3(b) until 2005. See Patrick Mulvany, TRIPs, Biodiversity and
Commonwealth Countries: Capacity Building Priorities for the 1999 review of
TRIPs Article 27.3 (b), at http://www.ukabc.org/TRIPs/trips99.pdf (last visited
Nov. 11 2004).
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TABLE 3: PLANT BREEDERS RIGHTS APPLICATIONS—COUNTRIES
GROUPED BY PER CAPITA INCOME, 1971-200273

73. International Convention for the Protection of New Varieties of
Plants, Union for the Protection of Plant Varieties Plant Variety Database CD
2003b (on file with author); KOO ET AL. supra note 68; KOO ET AL.,
PROTECTING AND LICENSING BIOLOGICAL INNOVATIONS: CROP RELATED
RESEARCH IN BRAZIL (Int’l. Food Policy Research Inst., Environment and
Production Technology Discussion Paper, forthcoming); US Plant Variety
Office,
Public
Database,
[hereinafter
UPOV
Database],
at
http://www.ams.usda.gov/science/PVPO/CertificatesDB.htm.
Bracketed
numbers indicate number of countries in each income class. Countries are
classified into income classes according to World Bank criteria. Countries with
2003 per capita gross national incomes greater than $9,386 are designated
high income; $3,036-9,385 are upper-middle income; $766-3,035 are lowermiddle income; and less than $765 are low income.
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The shifting geographical pattern of plant varietal
protection arises for several reasons. The growth in the total
number of applications is largely due to an increase in the rate
of applications per country per year.
Most high-income
countries had plant breeders’ rights legislation in place for
most of the period reported here, while in middle-income
countries there was a rapid growth in the number of countries
offering plant breeders’ rights, for example, two countries in
1971, five in 1985, eight in 1990 and fifteen in 2002. Increasing
rates of protection may reflect legal, economic, and institutional
factors. One would expect applications to increase over time as
awareness of the existence and effectiveness of plant breeders’
rights in a particular country increases and as the economic
costs of applying for and evaluating applications decline with
improved bureaucratic procedures.74
Notably, the number of plant breeders’ rights sought in
low-income countries is negligible - only twenty-three
applications from Kyrgyzstan.75 The principal proximate cause
of this situation is the lack of rights on offer in poor-countries.
More fundamentally, it reflects a range of economic influences
regarding the costs and benefits of securing breeders’ rights in
a particular jurisdiction.
To capture this cost-benefit calculus, Koo et al. use an
option value model to characterize the crop breeders’ decision to
apply for and retain varietal protection.76 While the costs of
gaining and securing plant variety protection are known with
reasonable surety, the sequence of future returns from a
varietal right is highly uncertain for many reasons.77 There are
uncertainties about the size of the appropriable seed market for
a given crop, the probability of commercial success of the
protected variety, and the extent of enforcement of assigned
property rights.78 Where required, breeders make periodic,

74. Some countries have expanded the scope of crops eligible for
protection overtime. In China, for instance, a total of ten species were eligible
for protection in September 1999, growing to thirty species by March 2002
(including five major cereals, two oil crops, two roots and tubers, ten
vegetables and fruits and eleven flowers and grasses but excluding cotton).
KOO ET AL., supra note 68, at 19 n.32.
75 UPOV Database, supra note 73.
76 KOO ET AL., supra note 68, at 3-6.
77 See generally KOO ET AL., supra note 68.
78 See generally id.
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often annual, renewal decisions preserving the right to pay
renewal fees and exercise their exclusionary rights in future
periods.79 Applying for, and subsequently renewing, plant
variety protection rights thereby allows breeders to reserve the
rights to potential future revenues, even if revenues in the
short term are negligible. Thus, the expected value of holding
plant variety rights consists of the current returns captured
from the coming year and the option to renew the right in the
subsequent year.
2. Foreign Plant Varietal Rights Applications
The UPOV data on varietal rights applications, shown in
Table 4, allow us to distinguish between domestic and foreign
applicants. Overall, approximately thirty-four percent (17,529
of a total of 51,258) of the applications filed in fifty UPOV
member countries during 1998–2002 were lodged by foreigners.
This substantial fraction of foreign applications indicates
extensive potential spillovers of varietal improvement research
done in one locale on seed market and production developments
elsewhere in the world. The intensity of foreign participation in
domestic varietal rights markets differs markedly. Looking
regionally, the fraction of the applications lodged by foreigners
was approximately thirty-one percent in high-income countries,
sixty-five percent in upper middle-income countries, twentyfive percent in lower-middle income countries, and thirty-nine
percent in low-income countries.
The country-by-country
participation of foreigners is even more variable. For example,
the share of foreign applications is eighty-five percent in
Switzerland and Canada, forty-two percent in the United
States, thirty-seven percent in the United Kingdom, twentyfour percent in Japan, sixteen percent in the Netherlands and
Germany, and eleven percent in France.80

79 See generally id.
80. Int’l Union for the Protection of New Varieties of Plants, Plant Variety
Protection
Statistics
for
the
Period
1998-2002
(2003),
at
http://www.upov.int/en/documents/c/37/c_37_7.pdf (last visited Nov. 11, 2004).
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TABLE 4: SHARE OF PLANT BREEDER RIGHTS APPLICATIONS
LODGED BY FOREIGNERS, 1998-200281
Economies

Total
Residents
(number of applications)

39,079
High income economies (23)
Upper middle income economies
5,583
(11)
Lower middle income economies
6,109
(12)
487
Low income economies (4)
51,258
Total (50)

Non-residents

26,893

12,186

1,945

3,638

4,592

1,517

299

188

33,729

17,529

3. European and United States Trends.
Worldwide, seed sales are estimated to be $30 billion
annually.82 While the economic value of seed markets within
the European Union, which is about $5.2 billion in total, is a
little less than U.S. seed sales, that is, about $5.2 billion
compared to $5.7 billion, respectively, Table 5 indicates that
since 1971, there are three times more PBR applications in
Europe than related applications in the United States. Much of
the difference may stem from multiple applications for the
same variety among national jurisdictions in Europe, whereas
only one application is required per variety in the United
States.83 Part of the difference may arise from the different
forms of varietal protection offered in Europe (plant breeders’
rights) versus the United States (plant patents, plant variety
protection certificates, and utility patents). About five percent
of all the plant breeders and related patent applications in the

81. Id. See tbl.3 for country income classification criteria. Bracketed
figures indicate number of countries included in the data.
82. Int’l Seed Federation, Estimated Size of the Internal Market for seed
at
and
Other
Planting
Material
of
Selected
Countries,
http://www.worldseed.org/statistics.html (last visited Oct. 30, 2004).
83. The information needed to create these data is publicly available, but
requires compiling the plant breeder’s rights data by scrutinizing each
individual varietal protection certificate for the first forty years the rights
were on offer in the United States
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United States are for utility patents, of which fifty-five percent
pertain to corn and forty percent to soybeans.84

84. See UPOV Database, supra note 73. The utility patent data represent
a preliminary tabulation by the authors based on patent-by-patent scrutiny of
4,080 patents from 1972-2003 assigned USPTO patent code 800 to identify
patents with claims that encompass plant varieties.
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TABLE 5: PLANT-RELATED INTELLECTUAL PROPERTY
APPLICATIONS IN THE EUROPEAN UNION AND THE UNITED
STATES85

85. Compiled from commissioned data obtained from the United States
Patent and Trademark Office, Office of Electronic Information Products for US
plant and utility patents; the US Plant Variety Protection Office’s public
access database for the US plant variety protection; and UPOV Database and
Community Plant Variety Office (CPVO) for data of European Union countries
and CPVO series respectively.
a. European Union aggregate includes applications for plant breeders’
rights in thirteen European countries. U.S. aggregate includes plant and
utility patents granted and plant variety protection certificate applications.
b. CPVO members currently include Austria, Belgium, Denmark, Finland,
France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal,
Spain, Sweden, and the United Kingdom. Individuals or companies from
member states of UPOV, but not a member of the European Union, can also
apply, provided that an agent domiciled in the Community has been
nominated. Since it was first implemented in 1995, around thirty-five percent
of these applications are lodged from the Netherlands, sixteen percent from
Germany, fourteen percent from France, nineteen percent from elsewhere in
the European Union and sixteen percent from outside the European Union.
c. Preliminary tabulation by authors based on patent-by-patent scrutiny
of the U.S. patent database to identify patents with claims that encompass
plant varieties.
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Four countries, the Netherlands, France, Germany and the
United Kingdom, account for most of the European
applications. Adding applications lodged with the Community
Plant Variety Office (CPVO) to those filed nationally, the
Netherlands accounted for thirty-five percent of the European
total, France twenty-two percent, Germany sixteen percent and
the United Kingdom eight percent.86 The number of plant
breeders’ rights applications filed with the CPVO has increased
over time, offsetting declines in the number of applications
lodged with national protection offices. In 1996, there were
1,385 applications lodged with the CPVO and a total of 2,766
applications made to individual national systems. By 2000,
almost equal numbers of plant breeders’ rights claims were
filed with the CPVO and the respective national offices (about
2,000 applications each), and in 2001 CPVO applications
(2,158) exceeded those filed with national offices (1,864).87
Regarding the types of crops for which varietal protection
is sought, ornamental crops account for more than half the
total applications in both the United States and Europe.88 In
the United States, cereal crops such as wheat and corn; oil and
fibers; and fruit crops have each made up more than ten
percent of the total number of applications since 1970.89
Ornamentals and fruits are mostly protected by plant patents,
while cereal, oil and fiber crops, and vegetables are usually

86. Prior to April 27, 1995 when the CPVO was established, a breeder
seeking protection for a variety throughout the European Union was required
to submit an application to each of the member states. Now with a single
application to the CPVO, a breeder can be granted varietal protection rights
throughout the European Union.
This European-wide system—CPVO
members currently include Austria, Belgium, Denmark, Finland, France,
Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain,
Sweden, and the exploit both a community plant variety right (CPVR) and a
national plant breeders’ right in relation to that variety. Individuals or
companies from member states of UPOV, but not a member of the European
Union, can also apply, provided that an agent domiciled in the Community has
been nominated. The duration of CPVR protection is twenty-five years for
most crops, and thirty years for potato, vine, and tree varieties. See
COMMUNITY PLANT VARIETY OFFICE, 2002 ANNUAL REPORT 11-12 (2003).
87. UPOV Database, supra note 73.
88. See Bonwoo Koo, et al., Plants & Intellectual Property: An
International Appraisal, 305 SCIENCE 1295-97 (2004).
89. Id.
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protected by plant variety rights.90 In Europe, cereals account
for more than a quarter of the total PBR applications, followed
by vegetable (ten percent), oil and fiber crop (five percent) and
fruit (five percent).91
B.

BIOTECHNOLOGY PATENTING PATTERNS

An initial foray into examining the international
dimensions of patent activity in biotechnology and specific
sectors, such as agriculture and health, is presented in Figure
1. Numbers of patent applications submitted to the World
Intellectual Property Organization (WIPO) under the Patent
Cooperation Treaty (PCT) (Panel a) and patents granted by the
European Patent Office (EPO) (Panel b) are plotted against the
year published. For this analysis, patent documents were
selected on the basis of the International Patent Classification
(IPC) scheme used by the patent offices. Data were obtained
for documents satisfying criteria for “biotechnology” and
further sub-divided into “agricultural biotechnology” and
“health biotechnology.” For this work, “biotechnology” refers to
“[t]he application of [s]cience and [t]echnology to living
organisms as well as parts, products and models thereof, to
alter living or non-living materials for the production of
knowledge, goods and services”, a definition used by the
Organisation for Economic Co-operation and Development.92
While initially agricultural biotechnology patent documents
exceeded health related documents both at EPO and WIPO, the
situation reversed in 1999. Furthermore, the spectacular rise
in patent filings in the late 1980s and through the 1990s
appears to be leveling off.

90. Id.
91. Id.
92. Organization for Economic Co-operation and Development, Scientific,
Industrial and Health Applications of Biotechnology, Statistical Definition of
Biotechnology,
at
http://www.oecd.org/document/42/0,2340,en_2649_34537_1933994_1_1_1_1,00.
html (last visited Nov. 11, 2004).
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FIGURE 1: BIOTECHNOLOGY PATENTS93
Panel (a): PCT Applications

Panel (b): European Patent Grants

93. See generally Biological Innovation for Open Society (BIOS)
[hereinafter BIOS Website], at http://www.bios.net/ (last visited Nov. 15, 2004)
(on file with authors). The data supporting this table was originally compiled
from information on the Center for the Application of Molecular Biology to
International Agriculture (CAMBIA) Intellectual Property Resource Database,
at http://www.cambiaip.org/Home/welcome.htm.
The information on the
CAMBIA Intellectual Property Resource Database was moved to the BIOS
site. A copy of the original material remains on file with the authors.
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The data presented here contrast with recently reported
analyses of Graff et al., who note drops in patent grants in
plant biotechnology at the EPO after peaking in 1994-1995.94
The differences may be due to disparities in the definition of
plant or agricultural biotechnology. The Graff et al. definition
comprises a description of the scope of technologies such as
genetic engineering of plants, plant genes, and plant breeding
methods covering a small subset of IPC codes and specific
technology keywords.95 In contrast, the definition used in this
paper encompasses broader aspects of plant biotechnology,
including genetic modification of plants, biocides, organismal or
enzymic-based
methods
for
preservation
of
foods,
microbiological treatment of water and soil, compositions
containing micro-organisms or enzymes, and processes using
micro-organisms or enzymes. The definitional differences are
highlighted by the order of magnitude difference in the number
of documents that satisfy the criteria. For example, in 2000,
the authors of this article obtained 8,859 PCT applications and
5,097 patents issued by the European Patent Office (EU
patents) for inventions concerning agricultural biotechnology
compared with around 625 PCT and 50 EU patent applications
and 112 patents for the narrower area of “plant biotechnology”
reported by Graff et al.96
The authors of this article have found that the percentage
of PCT applications in agricultural biotechnology has been on
the rise. In 1985, agricultural biotechnology applications were
4.0 percent of the total submitted.97 By 1990, they were 7.5
percent of the total, and in 2000 had risen to 9.7 percent of the
total.98 In 2000, ag-biotech patents granted in EPO were 18.5
percent of the total granted.99 Clearly further examination of
patent activity with an eye to the commercial and public good
consequences encompassing the changing geographical and
institutional origins of biotechnology innovations on a global

94. Gregory D. Graff et al., The Public-Private Structure of Intellectual
Property
Ownership
in
Agricultural
Biotechnology,
21
NATURE
BIOTECHNOLOGY 989, 990 (2003).
95. Id.
96. Id. See BIOS Website, supra note 93.
97. See id.
98. See id.
99. See id.
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scale, and their spillovers or transfer to other countries, will be
sensitive to the patents included in the source set of documents.
V. CROP BIOTECHNOLOGY USE
The evidence on the worldwide dissemination of
contemporary, bioengineered crop technologies is usefully
viewed in the context of the diffusion of the classically bred
crop varieties that preceded them.
A. CLASSICALLY BRED CROP VARIETIES
1. Gains in Productivity
“Worldwide, [around ninety-five] percent of major cereal
production gains during the past four decades came from
increased yields, which have more than doubled since 1961.”100
Increasing yields result from increased use of inputs such as
agricultural chemicals including fertilizers, herbicides, and
pesticides, irrigation water, and improved crop varieties.101 In
the developed world at least, the growth in crop yields began
picking up pace several hundred years ago. Looking in detail
at developments in U.S. wheat varieties since 1800, Alan L.
Olmstead and Paul W. Rhode, for example, estimated that
roughly one-half of the U.S. growth in labor productivity
between 1839 and 1909 was attributable to biological
innovations.102 Pardey et al. showed that wheat varietal
change in the United States accelerated during the twentieth
century: an average of 5.1 commercially successful wheat
varieties were introduced each year from 1901 to 1970; the rate
jumped to 21.6 varieties per year during the period 1971 to
Moreover, the creation of these new varieties
1990.103
continued to rely heavily on foreign germplasm.104 By the early

100. C. FORD RUNGE ET AL., ENDING HUNGER IN OUR LIFETIME: FOOD
SECURITY AND GLOBALIZATION 71 (2003).
101. See id. at 69.
102. Alan L. Olmstead & Paul W. Rhode, The Red Queen and the Hard
Reds: Productivity Growth in American Wheat, 1800-1940, 62 J. ECON. HIST.
929 (2002).
103. See PHILIP G. PARDEY ET AL., HIDDEN HARVEST: U.S. BENEFITS FROM
INTERNATIONAL RESEARCH AID (Int’l. Food Policy Research Inst. Food Policy
Report, September 1996), available at http://www.ifpri.org/pubs/fps/fps23.htm.
104. Id.
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1990s, one-fifth of the total U.S. wheat acreage and virtually all
the spring-wheat cropped in California were sown to varieties
with ancestry derived from the International Maize and Wheat
Improvement Center (CIMMYT) based in El Batán, Mexico.105
Pardey et al. estimated that the improved genetic makeup of
wheat varieties between 1970 and 1993 was worth almost $43
billion (in 1993 prices) to the United States, or the equivalent of
10.6 percent of the present value of wheat production during
this period, and that up to $13.7 billion of that total benefit was
attributable to varietal spill-ins from CIMMYT alone.106
There are long lags between committing research and
development dollars and realizing the returns on that
investment. Even in the United States it took decades to build
up the genetic resource base and train and deploy the scientists
skilled in classical genetic manipulation techniques before
reaping the really big dividends during the latter half of the
twentieth century.107 In the developing world, scientific crop
breeding lagged well behind. Beginning in the 1950s and
1960s, improved varieties became increasingly available to
farmers and yields rose: wheat yields went from one ton per
hectare or less in China and India in the mid-1960s to over two
and a half tons in India, and almost four tons in China, by the
late 1990s.108 Table 6 shows the rapid spread of modern rice,
wheat, and maize varieties throughout the developing world.
Asia embraced these new varieties most rapidly, while adoption
lagged in Sub-Saharan Africa. A striking feature of these data,
however, is the limited uptake of scientifically bred crop
varieties throughout most of the developing world as late as
1970. When virtually all the cropped acreage in rich countries
was sown to scientifically bred rice and wheat varieties, less
than one-third of the developing world’s rice acreage and just
one-fifth of its wheat acreage were planted to modern forms of
these crops.

105. Id. CIMMYT is the Spanish acronym for the International Maize and
Wheat Improvement Center.
106. Id.
107. See Pardey & Wright, supra note 1.
108. See id.
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TABLE 6: SHARE OF AREA PLANTED TO MODERN VARIETIES OF
RICE, WHEAT, AND MAIZE109

Regions
Sub-Saharan
Africa
West
Asia/North
Africa
Asia
(excluding
China)
China
Latin
America
All
Developing
Countries

Rice
Wheat
Maize
1970 1983 1991 1970 1977 1990 1997 1992 1996
(percentage of area planted)
4

5

n.a.

5

22

52

66

37

46

0

11

n.a.

5

18

42

66

26

n.a.

12
77

48
95

67
100

42
n.a.

69 88
n.a. 70

93
79

42
97

64
99

4

28

58

11

24

82

90

49

45

30

59

74

20

41

70

81

58

62

For these three food staples, much of the crop improvement
research involved publicly funded and conducted research. The
big innovation of the 1960s and 1970s for rice and wheat was
the development and release of increasing numbers of semidwarf varieties by national and international research agencies

109. See RUNGE ET AL., supra note 100; DEREK BYERLEE & PIEDAD MOYA,
CIMMYT, IMPACTS OF INTERNATIONAL WHEAT BREEDING RESEARCH IN THE
DEVELOPING WORLD 1966-90 (1993); Derek Byerlee, Modern Varieties,
Productivity, and Sustainability: Recent Experience and Emerging Challenges,
24 WORLD DEV. 697 (1996); Paul W. Heisey et al., Assessing the Benefits of
International Wheat Breeding Research: An Overview of the Global Wheat
Impacts Study, in CIMMYT 1998-1999 WORLD WHEAT FACTS AND TRENDS:
GLOBAL WHEAT RESEARCH IN A CHANGING WORLD: CHALLENGES AND
ACHIEVEMENTS (P.L. Pingali ed. 1999). For maize, see Michael L. Morris,
Overview of the World Maize Economy, in MAIZE SEED INDUSTRIES IN
DEVELOPING COUNTRIES (Michael L. Morris ed., 1998); MICHAEL L. MORRIS,
IMPACTS OF INTERNATIONAL MAIZE BREEDING RESEARCH IN DEVELOPING
COUNTRIES, 1966-1998 (2002). The designation “na” indicates that data is not
available. Modern varieties of rice and wheat refer mainly to semi-dwarf
varieties, for maize it includes hybrid and improved open pollinated varieties.
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bred using plant material and crop transformation techniques
that were entirely public domain.110 Almost all the resulting
improved varieties were made available without personal or
corporate intellectual property rights.
The public sector
performed most of the research, and in few jurisdictions were
intellectual property rights over the varieties themselves or the
techniques used to transform them even a legal option at that
time.
For corn the story is different. While publicly bred
varieties were, and remain, a feature of this crop, the private
sector presence is much more pronounced.111 Hybrid corn
technologies that took off in the United States in the 1930s and
later elsewhere offered significant protection for the
intellectual property embodied in them.112
This made it possible for breeders to appropriate a larger
share of varietal benefits than was possible for the selfreplicating forms of varietal transformations featured in rice
and wheat.113 For hybrid corn varieties, as long as the in-bred
lines were kept secret and laws were in place in the United
States and elsewhere to help preserve these trade secrets, the
cost of imitation was prohibitively large, enabling inventors to
appropriate significant shares of the benefits stemming from
their efforts.114
Table 6 indicates that the developing-country uptake of

110. Pardey et al., supra note 103.
111. Zvi Griliches, Hybrid Corn: An Explanation in the Economics of
Technological Change, 25 ECONOMITRICA, 501-522 (1957).
112. Id.
113. Hybrid technologies were also pursued for rice and wheat but less
extensively so. Mary Knudson and Vernon Ruttan document efforts to develop
hybrid wheat in the United States. Mary K Knudson & Vernon W. Ruttan,
Research and Development of a Biological Innovation: Commercial Hybrid
Wheat, 21 FOOD RES. INST. STUD. 45 (1988). Hybrid rice is grown extensively
in China, beginning in the mid-1960s. Since then, the area under hybrid rice
has increased steadily to about twenty-three percent in 1981 and sixty-one
percent in 2001. SHENGGEN FAN ET AL., NATIONAL AND INTERNATIONAL
AGRICULTURAL RESEARCH AND RURAL POVERTY: THE CASE OF RICE RESEARCH
IN INDIA AND CHINA 7-8 (Int’l Food Research Inst., Environment and
Production Technology Division Discussion Paper No. 109, September 2003).
Notably, profit potentials were not a contributing factor to the development
of this technology in China where the research was a government
undertaking.
114. Pardey & Wright, supra note 1.
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modern maize varieties has also been substantial, but less
extensive than the move to improved forms of rice and wheat
worldwide. This could partly be due to the greater proprietary
and private sector nature of maize varietal changes, but a
whole host of other influences could be operative as well. About
eighty-six percent of the improved acreage world wide is sown
to hybrids, the rest to open pollinated varieties.
2. Varietal Spillovers
While the agroecological specificities of much agricultural
research
and
development,
especially
many
crop
biotechnologies, limit the geographical scope of agricultural
innovations, there is overwhelming evidence that spatial
spillovers of technologies have played a pivotal part in
productivity improvements worldwide.
In reviewing the
economic studies of this phenomenon, Julian Alston concluded
that interstate or international research and development
spillovers might account for half or more of the total measured
productivity growth.115
Spillovers of crop varietal technologies have flowed in all
sorts of directions. Looking at the spill-ins to the United States
of varietal improvement research done at the international
research centers, specifically the CIMMYT in Mexico and the
International Rice Research Institute (IRRI) in the Philippines,
Pardey et al. estimated that, from 1970 to 1993, the U.S.
economy gained $3.4 billion to $13.7 billion from the use of
improved wheat varieties developed by CIMMYT depending on
the benefit attribution methods employed.116 In the same
twenty-three year period, they found that the U.S. economy
realized at least thirty million dollars and up to one billion
dollars through the use of rice varieties developed by the
IRRI.117
In more recent research, Pardey et al. quantified the
benefits from crop improvement research in Brazil and
attributed them to the Brazilian national agricultural research
agency (Embrapa), other public and private agencies operating

115. Julian M. Alston, Spillovers, 46 AUSTRALIAN J. AGRIC. & RESOURCE
ECON. 315, 338 (2002).
116. PARDEY ET AL., supra note 103.
117. Id.
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in Brazil, and spillovers from the Consultative Group on
International Agricultural Research (CGIAR) and the United
States.118 They found that, from 1994-2000, sixty-four percent
of the total benefits from varietal improvement for upland rice
in Brazil ($1,683 million in 1999) were from non-Embrapa
sources.119 Likewise, from 1985-2003, sixty-seven percent of
the total benefits from varietal improvement research for edible
beans ($677 million in 1999) came from non-Embrapa sources,
mostly within Brazil, whereas from 1981-2003, seventy-seven
percent of the total benefits from varietal improvement
research for soybeans, ($12,473 million in 1999) were due to
non-Embrapa sources, with twenty-two percent of the benefits
attributable to spill-ins from the United States.120
B. BIOENGINEERED CROP VARIETIES
Where the crop varieties and bioengineered traits
embodied in them perform well and are given approval for
commercial use, the rate of uptake has been rapid, although
contrary to some claims, not entirely unprecedented, even for
biological innovations used in agriculture. For example, Zvi
Griliches studied the uptake of hybrid corn technologies in the
United States and showed that there was a zero to fifty percent
increase in Iowa’s corn acreage sown to hybrid varieties in the
six years from 1932 to 1938 and reaching ninety percent by
1940.121 Clive James estimates that 58.7 million hectares were
planted to bioengineered crops worldwide in 2002, an increase
from 52.6 million hectares in the previous year and well up on
the 2.8 million hectares planted in 1996.122

118. PHILIP G. PARDEY ET AL., ASSESSING AND ATTRIBUTING THE BENEFITS
VARIETAL IMPROVEMENT RESEARCH IN BRAZIL (Int’l Food Policy
Research Inst. Research Report No. 136, 2004), available at
http://www.ifpri.org/.
119. Id.
120. Id.
121. Zvi Griliches, supra note 111, at 502 fig.1.
122. See Clive James, Global Review of Commercialized Transgenic Crops:
2002, (Int’l Service for the Acquisition of Agri- Biotech Applications (ISAAA),
ISAAA Briefs 2002), available at http://www.isaaa.org. In 1994 the FlavrSavrTM tomato, genetically engineered to delay softening so the tomato could
ripen on the vine and retain its “fresh picked” flavor, became the first
bioengineered crop to be grown commercially. See also, Michele C. Marra et
al., The Payoffs to Transgenic Field Crops: An Assessment of the Evidence, 5
43
(2003),
available
at
AGBIOFORUM
FROM
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Despite this growth, the geographical and technological
scope of bioengineered crops is still small. As indicated in
Figure 2, in 2002, the preponderance of the area under these
types of crops consisted of bioengineered soybeans, which
accounted for sixty-two percent of the total bioengineered
cropping area, while twenty-one percent of the area was sown
to bioengineered maize, twelve percent to cotton, and five
percent to canola.123 Just four countries accounted for ninetynine percent of the global total in 2002.124 Two-thirds of this
global total was planted in the United States, twenty-two
percent in Argentina, six percent in Canada and three percent
in China.125 Two traits dominate the picture, namely, herbicide
tolerance mainly in soybeans and canola and insect tolerance
mainly in corn and cotton, though there are some limited use of
bioengineered viral resistance in papaya and squash.126
FIGURE 2: AREA SOWN TO BIOENGINEERED CROPS
WORLDWIDE127

http://www.agbioforum.org./v5n2/v5n2a02-marra.htm.
123. James, supra note 122, at 11 tbl.4.
124. Id at 7 tbl.3.
125. NAT’L AG. STATISTICS SERVICE, U.S. DEP’T OF AGRICULTURE, ACREAGE
REPORTS (June 2003) [hereinafter NASS Report], available at
http://usda.mannlib.cornell.edu/reports/nassr/field/pcp-bba/; James, supra note
122, at 7 tbl.3.
126. James, supra note 122, at 11 tbl.4.
127. See id.
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As indicated in Figure 2, the developing country’s share of
global bioengineered crop area has grown from fourteen percent
of the world total in 1997 to about twenty-seven percent in
2002. Notably, plantings in just four countries, soybeans in
Argentina and cotton in China, South Africa, and for the first
time in 2002, India, account for the lion’s share of the
Finding
developing-country bioengineered acreage.128
bioengineered traits that deal successfully with local
production constraints is one thing, expressing them in specific
crop varieties that compete well locally against landraces and
conventionally bred varieties of the same crop, absent the
bioengineered trait, is another thing. Not surprisingly, the
bioengineered traits are being grown in developing-country
areas that are agroecologically similar to the rich countries for
which the traits were first developed, and in most cases involve
the identical crop varieties. For example, all the officially
approved Monsanto/DeltaPine bioengineered cotton varieties
grown in China are the same varieties grown in the United
States, while most of the bioengineered Chinese varieties are
based on older DeltaPine varieties introduced into China in the
1940s and 1950s.129 Likewise the transgenic cotton varieties
grown in Mexico are from the United States;130 and in South
Africa, NuCotn 37-B, an American variety, is widely used.131
This is precisely where the spillover costs are smallest and
consist mainly of local screening and regulatory approval costs
along with the costs of marketing the technology. That is,
disseminating these particular bioengineered crop varieties
involves only adaptive or imitative technology development
costs beyond the initial discovery costs, a much smaller cost
than inventing entirely new bioengineered traits and
successfully expressing those traits in locally superior varieties
of locally important crops.
The site-specificity of many agricultural biotechnologies

128. See id. at 5.
129. Carl .E. Pray et al., Five Years of Bt Cotton in China—The Benefits
Continue, 31 PLANT J. 423, 424 (2002).
130. Greg S. Traxler, Transgenic Cotton in Mexico: Economic and
Environmental Impacts, in THE ECONOMIC AND ENVIRONMENTAL IMPACTS OF
AGBIOTECHNOLOGY: A GLOBAL PERSPECTIVE 183 (2003).
131. Colin Thirtle et al., Can GM-Technologies Help the Poor? The Impact
of Bt Cotton in Makhathini Flats, KwaZulu-Natal, 31 WORLD DEV. 717, 719
(2003).
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arises from agroecological aspects, which defines the size of the
relevant market in a way that is much less common in other
industrial research and development. As Julian M. Alston and
Philip G. Pardey described, one way to think of this is in terms
of the unit costs of making local research results applicable to
other locations by adaptive research, which must be added to
the local research costs.132 Such costs grow with the size of the
market.133 Economies of size, scale, and scope in research
mean that unit costs fall with size of the research and
development enterprise, but these economies must be traded off
against the diseconomies of distance and adapting site-specific
results such as the costs of “transporting” the research results
to economically “more distant” locations.134 Thus, as the size of
the research enterprise increases, unit costs are likely to
decline at first because economies of size are relatively
important, but will eventually rise as the costs of economic
distance become ever-more important.
Given that the United States dominates the world totals,
its trends are worth scrutinizing. Ranked in terms of total
acreage, the world and U.S. crop relativities for 2002 are the
same—soybeans dominate, followed by corn and cotton.135
However, the intensity of use of bioengineered versus
classically bred crops differs between the Unites States and the
rest of the world. As indicated in Figure 3, the United States
uniformly makes more intensive use of bioengineered crops
than the rest of the world. While seventy-seven percent of the
U.S. canola crop was sown to bioengineered varieties in 2002,
the corresponding rest-of-world share was twelve percent.
Likewise, bioengineered soybeans covered seventy-one percent
of the U.S. soybean acreage and only twenty-eight percent of

132. Julian M. Alston, & Philip G. Pardey, The Economics of Agricultural
R&D Policy, in PAYING FOR AGRICULTURAL PRODUCTIVITY (Julian M. Alston
et al. eds., 1999).
133. A close analogy can be drawn with spatial market models of food
processing in which processing costs fall with throughput but input and output
transportation costs rise with throughput so that when the two elements of
costs are combined, a U-shaped average cost function is derived. See, e.g.,
Richard J. Sexton, Imperfect Competition in Agricultural Markets and the Role
of Cooperatives: A Spatial Analysis, 72 AM. J. AGRIC. ECON. 709, 714 fig.1
(1990).
134. See Alston & Pardey, supra note 132.
135. NASS Report, supra note 125.
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the rest-of-world soybean area.136 For cotton the corresponding
shares were seventy-one percent for the United States and
eleven percent for the rest of the world; for corn it was thirtyfour percent for the United States and 1.4 percent elsewhere.137
This reflects both technology and market realities. While the
dominant bioengineered traits such as those that target mainly
budworm/boll weevil complexes in cotton and European stem
borers in corn, as well as Roundup® and Liberty Link®
resistance in soybeans and canola have yield-enhancing or costreducing consequences for rest-of-world farmers, they are
especially consequential for United States producers.
In
addition, given their earlier regulatory approval in the United
States, these traits are now incorporated into a number of
locally optimized crop varieties.
FIGURE 3: BIOENGINEERED CROPPING INTENSITIES – UNITED
STATES VS REST-OF-THE-WORLD, 2002138

136. See Marra, supra note 122, at 43 (“In some U.S. states, the share of
2002 soybean acres planted to [Roundup Ready®] soybeans is approaching
[ninety percent]”), available at http://www.agbioforum.org./v5n2/v5n2a02marra.htm.
137. See James, supra note 122; NASS Report, supra note 125.
138. Data represent share of respective crop acreage in each region sown to
bioengineered varieties. See James, supra note 122, at 11 tbl.4; NASS Report,
supra note 125.
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VI. SUMMING UP
This paper demonstrates that the preponderance of
research conducted on bioengineered crops is carried out in rich
countries where the overwhelmingly large share of
biotechnology acreage is still to be found, and much of the
product development work is performed by private firms.
Moreover, most of the bioengineered traits and the specific crop
varieties that are planted in developing countries are spillovers
from, or adaptive modifications of, rich-country research. Only
when we achieve a reasonable rate of inventor appropriability
of the returns to the technologies that are applicable in lessdeveloped countries, combined with an economic infrastructure
that facilitates adoption of those technologies, can we expect a
significant private-sector role to emerge in the poorer parts of
the world.
This paper also draws attention to the comparatively low
rates of investment in public agricultural research and
development in developing countries, where government
revenues may be comparatively expensive due to lower tax
revenues, or have a comparatively high opportunity cost.139
Many less-developed countries are characterized by underinvestment in a host of other public goods, such as
transportation and communications infrastructure, schools,
hospitals, and the like, as well as agricultural science. These
other activities, like agricultural science, might also have high
social rates of return.140 In many less-developed countries,
where agriculture represents a much greater share of the total
economic activity, and where per capita incomes are much
lower, a meaningful investment in public agricultural research
might have a much more appreciable impact on individual
citizens. The problem, however, is that this burden is felt now,
while the payoff it promises may take a long time to come, and
will be much less visible when it does.
Even among the rich countries of the world, most have not
had very substantial private or public agricultural science
industries. Why, then, should we expect the poorest countries

139. Julian M. Alston & Philip G. Pardey, Developing Country Perspectives
on Agricultural R&D—New Pressures for Self Reliance?, in AGRICULTURAL
R&D POLICY IN THE DEVELOPING WORLD (forthcoming 2005).
140. See id. (noting political factors are also present).
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of the world to be more like the richest of the rich in this
regard?141 The lion’s share of the public, as well as private,
investment in agricultural science has been undertaken by a
small number of countries; generally, these countries have
undertaken the lion’s share of scientific research as well.142 An
important consideration is economies of size, scale, and scope in
research, which influence the optimal size and portfolio of a
given research institution.
In some cases the “optimal”
institution may efficiently provide research for a state or region
within a nation, but for some kinds of research the efficient
scale of institutions may be too great for an individual nation.
Many nations may be too small to achieve an efficient scale in
much if any of the relevant elements of their interests’ in crop
biotechnology research, except perhaps in certain types of
adaptive research.
Historically, there have been large spillovers of improved
varieties and the technology and know-how embodied in them
from one country to another. However, we cannot presume
that the rich countries of the world will play the same roles as
in the past.143 In particular, countries that in the past relied on
technological spillovers from the North may no longer have
that luxury available to them in the same ways or to the same
extent.144 This change can be seen as involving three elements.
First, the types of technologies being developed in the rich
countries may no longer be as readily applicable to lessdeveloped countries as they were in the past. The agenda in
richer countries is shifting away from areas like yield
improvement in major crops to other crop characteristics and
even to non-agricultural issues.145 Second, the private presence
in rich country agricultural research and development has
increased and many biotech companies are not as interested in
developing technologies for many less-developed country
applications.
Even where they have such technologies

141. See PARDEY & BIENTEMA, supra note 5, at 13 (noting the geographical
concentration among countries of particular classes of research—for instance
research into agricultural chemicals or machinery—is even greater than that
for agricultural R&D in total).
142. See id. at 11-12 (reporting the United States conducted forty-two
percent of the world’s total investment in all science in 1995).
143. See Alston & Pardey, supra note 139.
144. See id.
145. See id.
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available, often they are not interested in pursuing potential
markets in less developed countries.146 And third, those
technologies that are applicable and available are likely to
require more substantial local development and adaptation,
calling for more sophisticated and extensive forms of scientific
research and development than in the past. For instance, more
advanced skills in modern biotechnology or conventional
breeding may be required to take advantage of enabling
technologies or simply to make use of less-finished lines that
require additional work to tailor them to local production
environments.147 In short, different approaches may have to be
devised to make it possible for less-developed countries to
achieve equivalent access to technological potentials generated
by rich countries. In many instances, less-developed countries
may have to extend their own research and development efforts
to more fundamental areas of the science.
Some argue that strengthening intellectual property
regimes in poorer countries is one way of stimulating
investments in developing-country research and development
as well as efforts to commercialize crop technologies developed
elsewhere.148 Others argue that the number and breadth of
patents, plant breeders’ rights, and other forms of intellectual
property hinders the research and development required to
tackle food security concerns of poor countries.149 Binenbaum
et al. studied the situation for fifteen staple food crops of the
world and concluded there was undue concern that intellectual
property rights were currently limiting the freedom to operate
The
for research on developing-country food staples.150
Binenbaum et al. study reinforced the intellectual property
evidence assembled for some key enabling technologies used in
agriculture: intellectual property rights concerning crop
biotechnologies are overwhelmingly concentrated in rich-

146. See id.
147. See id.
148. See, e.g., Mark Schankerman, How Valuable Is Patent Protection?
Estimates by Technology Field, 29 RAND JOURNAL OF ECONOMICS 77, 104
(1998) (“Patent rights are clearly valuable, but they are not the main source of
private returns to inventive effort.”).
149. See, e.g., Eran Binenbaum et al., South-North Trade, Intellectual
Property Jurisdictions, & Freedom to Operate in Agricultural Research on
Staple Crops, 51 ECON. DEV. & CULTURAL CHANGE 309 (2003).
150. See id. at 317, 331.
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country jurisdictions, meaning poor-country research can
proceed largely unencumbered by any intellectual property
restraints.151 Binenbaum et al. also showed that bilateral trade
in food staples from poor- to rich-countries in which intellectual
property was presumptively in force was meager and limited to
just a few crops from a few poor countries,152 meaning the
results of this research can be disseminated and used with few
if any intellectual property impediments if the intent is to feed
and clothe poor people in poor countries.
As things stand today, the constraints to conducting
modern crop biotechnology research in developing countries
appear to lie largely beyond intellectual property concerns.
Market considerations limit substantial private interests for
many crops in many developing countries, and the intensity of
public investments is generally low for reasons that do not
seem likely to change soon.153 Intellectual property rights may
have a role to play in stimulating efforts to commercialize crops
in developing countries, especially helping to harness spill-in
technologies developed elsewhere, but, at least in the nearer
term, they will be no substitute for rich and poor country
governments alike reinvesting in the research and development
required to maintain and continue adding to the crop yields
necessary in the decades ahead.

151. See id. at 317-18.
152. See id. at 323.
153. See Ismail Serageldin, Changing Agendas for Agricultural Research,
in AGRICULTURAL SCIENCE POLICY: CHANGING GLOBAL AGENDAS 13, 19
(Julian M. Alston et al. eds., 2001) (Some even see a scientific apartheid
taking shape, with large parts of the developing world being left behind or
denied the prospects science has to offer for growth, development, and
prosperity).

